BEIJING, June 21,
2023 /PRNewswire/ -- iHuman Inc. (NYSE: IH)
("iHuman" or the "Company"), a leading provider of tech-powered,
intellectual development products in China, today announced its unaudited financial
results for the first quarter ended March 31, 2023.
First Quarter 2023 Highlights
- Revenues reached a record-high of RMB265.2 million (US$38.6
million), compared with RMB242.7
million in the same period last year.
- Gross profit was RMB185.6 million
(US$27.0 million), compared with
RMB169.9 million in the same period
last year.
- Operating income reached a record-high of RMB56.7 million (US$8.3
million), a year-over-year increase of 402.3%.
- Adjusted operating income[1] reached a record-high
of RMB59.1 million (US$8.6 million), a year-over-year increase of
346.3%.
- Net income reached a record-high of RMB53.6 million (US$7.8
million), a year-over-year increase of 308.9%.
- Adjusted net income[1] reached a record-high of
RMB56.1 million (US$8.2 million), a year-over-year increase of
271.8%.
- Average total MAUs[2] for the first quarter were
21.09 million, a year-over-year increase of 14.7%.
[1] "Adjusted operating
income" and "adjusted net income" exclude share-based compensation
expenses. Please see "Non-GAAP Financial Measures" and "Unaudited
Reconciliation of GAAP and non-GAAP Results" at the end of this
press release.
|
[2] "Average total
MAUs" refers to the monthly average of the sum of the MAUs of each
of the Company's apps during a specific period, which is counted
based on the number of unique mobile devices through which such app
is accessed at least once in a given month, and duplicate access to
different apps is not eliminated from the total MAUs
calculation.
|
[3] "Paying
users" refers to users who paid subscription fees for premium
content on any of the Company's apps during a specific period; a
user who makes payments across different apps using the same
registered account is counted as one paying user, and a user who
makes payments for the same app multiple times in the same period
is counted as one paying user.
|
Dr. Peng Dai, Director and Chief Executive Officer of
iHuman, commented, "I am pleased to announce a strong start to
2023, with another quarter of growth in both our top- and
bottom-lines. We also made further progress in enhancing our
comprehensive portfolio across various markets. Domestically, we
released several important product updates to optimize the user
experience and boost user engagement. For example, we
upgraded iHumanpedia with an innovative module called "AI
Talk", an AI-generated content (AIGC) chatbot designed for
children. Leveraging the latest AIGC technologies, this innovative
module can understand and respond to children's questions and
answer with personalized feedback and guidance. As one of the first
kid-friendly chatbots being trialed in China, it demonstrates our ongoing commitment
to leveraging cutting-edge AI technologies to nurture children's
holistic development. In addition to improving the user experience
through innovative technologies, we also enhanced user engagement
by incorporating more interactive features into our products.
During the quarter, we launched "Creative Zone", an
interactive module within iHuman Coding that enables
children to share their coding projects with peers, both
within and outside the app. This new feature allows children to try
out each other's work, give thumbs up to projects they enjoy, and
interact with each other through various in-app events. This helps
improve the activeness in our community while at the same time
nurturing children's logical thinking and creativity.
Internationally, we continued to execute our product roadmap and
are excited to welcome a new member to our bekids product
family called Gogo Town.
This vibrant mini world app offers a diverse range of daily
life-themed interactive activities that support early childhood
development and allow children to explore from the
activities they love. In the meantime, we are thrilled to see
the growing market acceptance of our existing products. For
example, our open-ended fantasy adventure-themed app, Aha
World, has experienced significant growth in first-time daily
downloads since its launch last quarter. Even more impressively, it
has swiftly ascended to the top ten most popular children's apps on
Apple's app store & Google Play in both the US and Europe recently. The strong momentum not only
speaks to the widespread appeal of the app, but also signifies its
great potential in the international market. Moving forward, we
will continue to build upon our industry-leading product matrix,
driving the sustainable growth of our business."
Ms. Vivien Weiwei Wang, Director
and Chief Financial Officer of iHuman, added, "In the first
quarter, we sustained the business momentum we built up over the
last several quarters, resulting in a new record high revenue of
RMB265.2 million. This helped us
achieve our fifth consecutive quarter of profitability, with net
income increasing by 308.9% year-over-year to hit another
record-high of RMB53.6 million. The
continuous balanced financial performance was made possible through
ongoing investments in areas crucial to our sustainable long-term
growth, such as high-quality content, innovative technologies, and
our effective efforts to enhance operational excellence. While
working relentlessly to strengthen our in-house capabilities, we
constantly seek out new partnerships and collaborations to better
serve the diverse needs of our users. During the quarter, we joined
forces with major industry players such as Post &
Telecom Press and its affiliate Children's Fun Publishing Co. Ltd.,
one of the leading publishers of children's books in China. Together, we will explore innovative
ways to enhance both the digital and traditional reading
experience for children in order to offer a wider range of
high-quality content to young readers. Post & Telecom Press is
a prominent Chinese publishing house under the Ministry of Industry
and Information Technology of China. These partnerships not only reflect
important industry endorsements of our leadership position in
child-oriented content and technologies, but also provide us with
valuable expertise and complementary resources to our
in-house capabilities. Looking ahead, we will continue to
invest in key strategic priorities and expand the industrial
ecosystem while maintaining a healthy balance between growth and
profitability."
First Quarter 2023 Unaudited Financial Results
Revenues
Revenues were RMB265.2 million
(US$38.6 million), an increase of
9.3% from RMB242.7 million in the
same period last year, primarily driven by enhanced
user engagement.
Average total MAUs for the quarter were 21.09 million, an
increase of 14.7% year-over-year from 18.39 million in the same
period last year. The number of paying users[3] was 1.50
million.
Cost of Revenues
Cost of revenues was RMB79.6
million (US$11.6 million),
an increase of 9.4% from RMB72.8
million in the same period last year, primarily due to an
increase in channel costs, which was in line with the Company's
revenue expansion.
Gross Profit and Gross Margin
Gross profit was RMB185.6 million (US$27.0 million), an increase of 9.2% from
RMB169.9 million in the same period
last year. Gross margin was 70.0%, maintaining the same level of
70.0% in the same period last year.
Operating Expenses
Total operating expenses were RMB128.8
million (US$18.8 million), a
decrease of 18.8% from RMB158.6
million in the same period last year.
Research and development expenses were RMB61.7 million (US$9.0
million), a decrease of 36.2% from RMB96.6 million in the same period last year,
primarily due to payroll-related cost savings and decreased
outsourcing expenses as a result of the continued optimization of
our operational efficiency.
Sales and marketing expenses were RMB40.4 million (US$5.9 million), an increase of 12.6% from
RMB35.9 million in the same period
last year, primarily due to increased strategic investments in
seasonal promotional activities.
General and administrative expenses were RMB26.7 million (US$3.9
million), compared with RMB26.1
million in the same period last year.
Operating Income
Operating income was RMB56.7
million (US$8.3 million), an
increase of 402.3% from RMB11.3
million in the same period last year.
Excluding share-based compensation expenses, adjusted operating
income was RMB59.1 million
(US$8.6 million), an increase of
346.3% from RMB13.3 million in the
same period last year.
Net Income
Net income was RMB53.6 million
(US$7.8 million), an increase of
308.9% from RMB13.1 million in the
same period last year.
Adjusted net income was RMB56.1
million (US$8.2 million), an
increase of 271.8% from RMB15.1
million in the same period last year.
Basic and diluted net income per ADS were RMB1.01 (US$0.15)
and RMB0.99 (US$0.14), respectively, compared with
RMB0.25 and RMB0.24 in the same period last year. Each ADS
represents five Class A ordinary shares of the Company.
Adjusted diluted net income per ADS was RMB1.04 (US$0.15),
compared with RMB0.28 in the same
period last year.
Deferred Revenue and Customer
Advances
Deferred revenue and customer advances were RMB362.1 million (US$52.7
million) as of March 31, 2023,
compared with RMB379.1 million as of
December 31, 2022.
Cash, Cash Equivalents and Time Deposits
Cash, cash equivalents and time deposits were RMB1,033.6 million (US$150.5 million) as of March 31, 2023, compared with RMB1,050.0 million as of December 31, 2022.
Exchange Rate Information
The U.S. dollar (US$) amounts disclosed in this press release,
except for those transaction amounts that were actually settled in
U.S. dollars, are presented solely for the convenience of the
reader. The conversion of Renminbi (RMB) into US$ in this press
release is based on the exchange rate set forth in the H.10
statistical release of the Board of Governors of the Federal
Reserve System as of March 31, 2023,
which was RMB6.8676 to US$1.00. The percentages stated in this press
release are calculated based on the RMB amounts.
Non-GAAP Financial Measures
iHuman considers and uses non-GAAP financial measures, such as
adjusted operating income, adjusted net income and adjusted diluted
net income per ADS, as supplemental metrics in reviewing and
assessing its operating performance and formulating its business
plan. The presentation of non-GAAP financial measures is not
intended to be considered in isolation or as a substitute for the
financial information prepared and presented in accordance with
accounting principles generally accepted in the United States of America ("U.S. GAAP").
iHuman defines adjusted operating income, adjusted net income and
adjusted diluted net income per ADS as operating income, net income
and diluted net income per ADS excluding share-based compensation
expenses, respectively. Adjusted operating income, adjusted net
income and adjusted diluted net income per ADS enable iHuman's
management to assess its operating results without considering the
impact of share-based compensation expenses, which are non-cash
charges. iHuman believes that these non-GAAP financial measures
provide useful information to investors in understanding and
evaluating the Company's current operating performance and
prospects in the same manner as management does, if they so
choose.
Non-GAAP financial measures are not defined under U.S. GAAP and
are not presented in accordance with U.S. GAAP. Non-GAAP financial
measures have limitations as analytical tools, which possibly do
not reflect all items of expense that affect our operations.
Share-based compensation expenses have been and may continue to be
incurred in our business and are not reflected in the presentation
of the non-GAAP financial measures. In addition, the non-GAAP
financial measures iHuman uses may differ from the non-GAAP
measures used by other companies, including peer companies, and
therefore their comparability may be limited. The presentation of
these non-GAAP financial measures is not intended to be considered
in isolation from or as a substitute for the financial information
prepared and presented in accordance with GAAP.
Safe Harbor Statement
This announcement contains forward-looking statements. These
statements are made under the "safe harbor" provisions of the
United States Private Securities Litigation Reform Act of 1995.
These forward-looking statements can be identified by terminology
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar statements.
Statements that are not historical facts, including statements
about iHuman's beliefs and expectations, are forward-looking
statements. Among other things, the description of the management's
quotations in this announcement contains forward-looking
statements. iHuman may also make written or oral forward-looking
statements in its periodic reports to the U.S. Securities and
Exchange Commission (the "SEC"), in its annual report to
shareholders, in press releases and other written materials, and in
oral statements made by its officers, directors or employees to
third parties. Forward-looking statements involve inherent risks
and uncertainties. A number of factors could cause actual results
to differ materially from those contained in any forward-looking
statement, including but not limited to the following: iHuman's
growth strategies; its future business development, financial
condition and results of operations; its ability to continue to
attract and retain users, convert non-paying users into paying
users and increase the spending of paying users, the trends in, and
size of, the market in which iHuman operates; its expectations
regarding demand for, and market acceptance of, its products and
services; its expectations regarding its relationships with
business partners; general economic and business conditions;
regulatory environment; and assumptions underlying or related to
any of the foregoing. Further information regarding these and other
risks is included in iHuman's filings with the SEC. All information
provided in this press release is as of the date of this press
release, and iHuman does not undertake any obligation to update any
forward-looking statement, except as required under applicable
law.
About iHuman Inc.
iHuman Inc. is a leading provider of tech-powered, intellectual
development products in China that
is committed to making the child-rearing experience easier for
parents and transforming cognitive development into a fun journey
for children. Benefiting from a deep legacy that combines over two
decades of experience in the parenthood industry, superior original
content, advanced high-tech innovation DNA and research &
development capabilities with cutting-edge technologies, iHuman
empowers parents with tools to make the child-upbringing experience
more efficient. iHuman's unique, fun and interactive product
offerings stimulate children's natural curiosity and exploration.
The Company's comprehensive suite of innovative and high-quality
products include self-directed apps, interactive content and smart
devices that cover a broad variety of areas to develop children's
abilities in speaking, critical thinking, independent reading and
creativity, and foster their natural interest in traditional
Chinese culture. Leveraging advanced technological capabilities,
including 3D engines, AI/AR functionality, and big data analysis on
children's behavior & psychology, iHuman believes it will
continue to provide superior experience that is efficient and
relieving for parents, and effective and fun for children, in
China and all over the world,
through its integrated suite of tech-powered, intellectual
development products.
For more information about iHuman, please visit
https://ir.ihuman.com/.
For investor and media enquiries, please contact:
iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86 10 5780-6606
E-mail: ir@ihuman.com
Christensen
In China
Mr. Eric Yuan
Phone: +86-13801110739
E-mail: eric.yuan@christensencomms.com
In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com
iHuman Inc.
UNAUDITED CONDENSED
CONSOLIDATED BALANCE SHEETS
(Amounts in thousands of Renminbi ("RMB") and U.S. dollars
("US$")
except for number of
shares, ADSs, per share and per ADS
data)
|
|
|
|
|
|
|
|
December
31,
|
|
March
31,
|
|
March
31,
|
|
2022
|
|
2023
|
|
2023
|
|
RMB
|
|
RMB
|
|
US$
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
Current
assets
|
|
|
|
|
|
Cash and cash
equivalents
|
1,049,999
|
|
923,635
|
|
134,492
|
Time
deposits
|
-
|
|
109,947
|
|
16,010
|
Accounts receivable,
net
|
79,614
|
|
81,475
|
|
11,864
|
Inventories,
net
|
19,127
|
|
14,884
|
|
2,167
|
Amounts due from
related parties
|
2,286
|
|
1,976
|
|
288
|
Prepayments and other
current assets
|
102,765
|
|
104,232
|
|
15,177
|
Total current
assets
|
1,253,791
|
|
1,236,149
|
|
179,998
|
Non-current
assets
|
|
|
|
|
|
Property and
equipment, net
|
9,205
|
|
8,288
|
|
1,207
|
Intangible assets,
net
|
24,872
|
|
23,362
|
|
3,402
|
Operating
lease right-of-use assets
|
12,782
|
|
8,275
|
|
1,205
|
Long-term
investment
|
26,333
|
|
26,333
|
|
3,834
|
Other non-current
assets
|
6,416
|
|
6,068
|
|
881
|
Total non-current
assets
|
79,608
|
|
72,326
|
|
10,529
|
Total
assets
|
1,333,399
|
|
1,308,475
|
|
190,527
|
|
|
|
|
|
|
LIABILITIES
|
|
|
|
|
|
Current
liabilities
|
|
|
|
|
|
Accounts
payable
|
24,206
|
|
21,579
|
|
3,142
|
Deferred revenue and
customer advances
|
379,063
|
|
362,116
|
|
52,728
|
Amounts due to related
parties
|
6,944
|
|
13,194
|
|
1,921
|
Accrued expenses and
other current liabilities
|
144,717
|
|
94,946
|
|
13,825
|
Current operating
lease liabilities
|
6,123
|
|
1,624
|
|
236
|
Total current
liabilities
|
561,053
|
|
493,459
|
|
71,852
|
Non-current
liabilities
|
|
|
|
|
|
Non-current operating
lease liabilities
|
2,894
|
|
2,583
|
|
376
|
Total non-current
liabilities
|
2,894
|
|
2,583
|
|
376
|
Total
liabilities
|
563,947
|
|
496,042
|
|
72,228
|
SHAREHOLDERS'
EQUITY
|
|
|
|
|
|
Ordinary shares (par
value of US$0.0001 per share,
700,000,000 Class A shares authorized as of
December
31, 2022 and March 31, 2023; 125,122,382 Class A
shares issued and 121,722,467 outstanding as of
December 31, 2022; 125,122,382 Class A shares
issued
and 120,219,182 outstanding as of March 31, 2023;
200,000,000 Class B shares authorized, 144,000,000
Class B ordinary shares issued and outstanding as
of
December 31, 2022 and March 31, 2023; 100,000,000
shares (undesignated) authorized, nil shares
(undesignated) issued and outstanding as of December
31,
2022 and March 31, 2023)
|
185
|
|
185
|
|
27
|
Additional paid-in
capital
|
1,079,099
|
|
1,081,506
|
|
157,479
|
Treasury
stock
|
(7,123)
|
|
(14,006)
|
|
(2,039)
|
Statutory
reserves
|
7,967
|
|
7,967
|
|
1,160
|
Accumulated other
comprehensive income
|
10,497
|
|
4,308
|
|
627
|
Accumulated
deficit
|
(321,173)
|
|
(267,527)
|
|
(38,955)
|
Total shareholders'
equity
|
769,452
|
|
812,433
|
|
118,299
|
Total liabilities
and shareholders' equity
|
1,333,399
|
|
1,308,475
|
|
190,527
|
iHuman Inc.
UNAUDITED CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands of Renminbi ("RMB") and U.S. dollars
("US$")
except for number of
shares, ADSs, per share and per ADS data)
|
|
|
|
For the three months
ended
|
|
March
31,
|
|
March
31,
|
|
March
31,
|
|
2022
|
|
2023
|
|
2023
|
|
RMB
|
|
RMB
|
|
US$
|
|
|
|
|
|
|
Revenues
|
242,679
|
|
265,203
|
|
38,617
|
Cost of
revenues
|
(72,797)
|
|
(79,636)
|
|
(11,596)
|
|
|
|
|
|
|
Gross
profit
|
169,882
|
|
185,567
|
|
27,021
|
|
|
|
|
|
|
Operating
expenses
|
|
|
|
|
|
Research and
development expenses
|
(96,625)
|
|
(61,673)
|
|
(8,980)
|
Sales and marketing
expenses
|
(35,906)
|
|
(40,435)
|
|
(5,888)
|
General and
administrative expenses
|
(26,058)
|
|
(26,735)
|
|
(3,893)
|
Total operating
expenses
|
(158,589)
|
|
(128,843)
|
|
(18,761)
|
Operating
income
|
11,293
|
|
56,724
|
|
8,260
|
Other income,
net
|
3,347
|
|
6,082
|
|
886
|
Income before income
taxes
|
14,640
|
|
62,806
|
|
9,146
|
Income tax
expenses
|
(1,522)
|
|
(9,160)
|
|
(1,334)
|
Net
income
|
13,118
|
|
53,646
|
|
7,812
|
|
|
|
|
|
|
Net income per
ADS:
|
|
|
|
|
|
-
Basic
|
0.25
|
|
1.01
|
|
0.15
|
-
Diluted
|
0.24
|
|
0.99
|
|
0.14
|
|
|
|
|
|
|
Weighted average
number of ADSs:
|
|
|
|
|
|
-
Basic
|
53,476,316
|
|
53,205,925
|
|
53,205,925
|
-
Diluted
|
54,060,837
|
|
54,033,560
|
|
54,033,560
|
|
|
|
|
|
|
Total share-based
compensation expenses included in:
|
|
|
|
|
|
Cost of
revenues
|
64
|
|
98
|
|
14
|
Research and
development expenses
|
967
|
|
638
|
|
93
|
Sales and marketing
expenses
|
(88)
|
|
379
|
|
55
|
General and
administrative expenses
|
1,014
|
|
1,292
|
|
188
|
|
|
|
|
|
|
iHuman Inc.
UNAUDITED
RECONCILIATION OF GAAP AND NON-GAAP RESULTS
(Amounts in thousands of Renminbi ("RMB") and U.S. dollars
("US$")
except for number of
shares, ADSs, per share and per ADS data)
|
|
|
|
For the three months
ended
|
|
March
31,
|
|
March
31,
|
|
March
31,
|
|
2022
|
|
2023
|
|
2023
|
|
RMB
|
|
RMB
|
|
US$
|
|
|
|
|
|
|
Operating
income
|
11,293
|
|
56,724
|
|
8,260
|
Share-based
compensation expenses
|
1,957
|
|
2,407
|
|
350
|
Adjusted operating
income
|
13,250
|
|
59,131
|
|
8,610
|
|
|
|
|
|
|
Net
income
|
13,118
|
|
53,646
|
|
7,812
|
Share-based
compensation expenses
|
1,957
|
|
2,407
|
|
350
|
Adjusted net
income
|
15,075
|
|
56,053
|
|
8,162
|
|
|
|
|
|
|
Diluted net income per
ADS
|
0.24
|
|
0.99
|
|
0.14
|
Impact of non-GAAP
adjustments
|
0.04
|
|
0.05
|
|
0.01
|
Adjusted diluted net
income per ADS
|
0.28
|
|
1.04
|
|
0.15
|
|
|
|
|
|
|
Weighted average number
of ADSs – diluted
|
54,060,837
|
|
54,033,560
|
|
54,033,560
|
Weighted average
number of ADSs – adjusted
|
54,060,837
|
|
54,033,560
|
|
54,033,560
|
|
|
|
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-first-quarter-2023-unaudited-financial-results-301856185.html
SOURCE iHuman Inc.